Prot #I5B-EW-JGDI: An Open-Label Study to Evaluate the Pharmacokinetics of Doxorubicin following the Concomitant Intravenous Administration of Olaratumab (IMC-3G3) to Patients with Advanced Soft Tissue Sarcoma

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/21/151/31/20

Funding

  • Covance Inc. (Prot #I5B-EW-JGDI)
  • Eli Lilly and Company (Prot #I5B-EW-JGDI)